Black C N, Penninx B W J H, Bot M, Odegaard A O, Gross M D, Matthews K A, Jacobs D R
Department of Psychiatry, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, CA, USA.
Transl Psychiatry. 2016 Feb 23;6(2):e743. doi: 10.1038/tp.2016.5.
Depression may be accompanied by increased oxidative stress and decreased circulating anti-oxidants. This study examines the association between depressive symptoms, F2-isoprostanes and carotenoids in a US community sample. The study includes 3009 participants (mean age 40.3, 54.2% female) from CARDIA (Coronary Artery Risk Development in Young Adults). Cross-sectional analyses were performed on data from the year 15 examination (2000-2001) including subjects whose depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) and had measurements of plasma F2-isoprostanes (gas chromatography/mass spectrometry) or serum carotenoids (high-performance liquid chromatography). Carotenoids zeaxanthin/lutein, β-cryptoxanthin, lycopene, α-carotene, β-carotene were standardized and summed. Longitudinal analyses were conducted using the data from other examinations at 5-year intervals. Cross-lagged analyses investigated whether CES-D predicted F2-isoprostanes or carotenoids at the following exam, and vice versa. Regression analyses were controlled for sociodemographics, health and lifestyle factors. F2-isoprostanes were higher in subjects with depressive symptoms (CES-D ⩾ 16) after adjustment for sociodemographics (55.7 vs 52.0 pg ml(-1); Cohen's d = 0.14, P < 0.001). There was no difference in F2-isoprostanes after further adjustment for health and lifestyle factors. Carotenoids were lower in those with CES-D scores ⩾ 16, even after adjustment for health and lifestyle factors (standardized sum 238.7 vs 244.0, Cohen's d = -0.16, P < 0.001). Longitudinal analyses confirmed that depression predicts subsequent F2-isoprostane and carotenoid levels. Neither F2-isoprostanes nor carotenoids predicted subsequent depression. In conclusion, depressive symptoms were cross-sectionally and longitudinally associated with increased F2-isoprostanes and decreased carotenoids. The association with F2-isoprostanes can largely be explained by lifestyle factors, but lower carotenoids were independently associated with depressive symptoms.
抑郁症可能伴有氧化应激增加和循环抗氧化剂减少。本研究调查了美国社区样本中抑郁症状、F2-异前列腺素和类胡萝卜素之间的关联。该研究纳入了来自CARDIA(青年成人冠状动脉风险发展研究)的3009名参与者(平均年龄40.3岁,54.2%为女性)。对第15年检查(2000 - 2001年)的数据进行横断面分析,这些数据包括使用流行病学研究中心抑郁量表(CES-D)评估抑郁症状且测量了血浆F2-异前列腺素(气相色谱/质谱法)或血清类胡萝卜素(高效液相色谱法)的受试者。类胡萝卜素玉米黄质/叶黄素、β-隐黄质、番茄红素、α-胡萝卜素、β-胡萝卜素进行标准化并求和。使用每隔5年的其他检查数据进行纵向分析。交叉滞后分析调查了CES-D是否能预测下一次检查时的F2-异前列腺素或类胡萝卜素水平,反之亦然。回归分析对社会人口统计学、健康和生活方式因素进行了控制。在对社会人口统计学因素进行调整后,有抑郁症状(CES-D⩾16)的受试者F2-异前列腺素水平更高(55.7对52.0 pg/ml(-1);Cohen's d = 0.14,P < 0.001)。在进一步对健康和生活方式因素进行调整后,F2-异前列腺素水平没有差异。CES-D评分⩾16的受试者类胡萝卜素水平较低,即使在对健康和生活方式因素进行调整后也是如此(标准化总和238.7对244.0,Cohen's d = -0.16,P < 0.001)。纵向分析证实抑郁症可预测随后的F2-异前列腺素和类胡萝卜素水平。F2-异前列腺素和类胡萝卜素均不能预测随后的抑郁症。总之,抑郁症状在横断面和纵向均与F2-异前列腺素增加和类胡萝卜素减少相关。与F2-异前列腺素的关联在很大程度上可由生活方式因素解释,但类胡萝卜素水平较低与抑郁症状独立相关。